With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
It’s catchy to say, but don’t get caught not knowing what you’re talking about. Good thing this article in last month’s JAMA Onc will get you up to speed on the general topic of sequencing plasma cell-free DNA (aka liquid biopsies). The important points are understanding the different ways of performing liquid biopsies, the potential uses, and (most importantly) the major limitations of the information they provide. Though the data isn’t quite there yet, there is undoubtedly great promise for the future use of this non-invasive technique. And at least now we know what we’re talking about.